随机分组对照原发性肝癌中医辨证论治与中药合并化疗的疗效观察  

Observation on difference between treating primary carcinoma of the liver based on syndrome differentiation and the TCM medicine plus chemotherapy

作　　者：彭喜娜 

机构地区：[1]南阳市中医院,河南南阳473000

出　　处：《中医临床研究》2016年第35期54-55,共2页Clinical Journal Of Chinese Medicine

摘　　要：目的:通过随机分组对照研究方法分析原发性肝癌患者应用中医辨证论治与中药合并化疗的疗效差异。方法:纳入我院住院部在2015年1月-2015年5月间收治的原发性肝癌患者60例作为观察对象,按照入院编号奇偶性进行分组,分为对照组、观察组,各30例。对照组患者应用中药合并化疗治疗,观察组患者应用中医辨证论治方法进行治疗。对两组患者的临床疗效进行对比分析。结果:观察组患者经治疗后总有效率为90.00%(27/30),显著高于对照组的66.67%(20/30),组间对比差异显著且具有统计学意义。结论:原发性肝癌患者应用中医辨证论治的效果优于常规中药合并化疗的效果,对提高疗效有积极影响,可供临床推广。Objective： To investigate difference between efficacy of syndrome differentiation and the TCM medicine plus chemotherapy on primary carcinoma of the liver. Methods： From January 2015 to May 2015, 60 patients in our hospital were divided into two groups, 30 cases for each. The control group was given the TCM medicine plus chemotherapy; and the observation group was given syndrome differentiation. Efficacy in two groups were compared. Results： The total efficiency was 90.00% （27/30） in the observation group, higher than 66.67% in the control group （20/30） （P〈0.05）. Conclusion： Syndrome differentiation on primary carcinoma of the liver shows a better effect, and is worthy of promotion.

关 键 词：原发性肝癌 中医辨证论治 化疗 疗效 

分 类 号：R735.7[医药卫生—肿瘤]